BioCatalystWatch
TRVIWorkspace / TRVI / OverviewCompany library
Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc.

Trevi Therapeutics, Inc. (TRVI)

Website

Price
Market cap
Next catalystLAKE SSRE outcome report early in Q1 2027, based on projected enrollmentHaduvio — LAKE · Phase 2 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P2P3FilingApproved
Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P2P3FilingApproved

Other pipelines

Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P2P3FilingApproved

History / paused

Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P2P3FilingApproved
Haduvio

Kappa opioid receptor (KOR) × Mu opioid receptor (MOR)

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TRVI PR & News

PR & News

TRVI SEC archive